{"id":"W2006827588","doi":"10.1038/bjc.2014.497","title":"A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Moffitt Cancer Center","keywords":"Medicine; Rash; Internal medicine; PI3K/AKT/mTOR pathway; Cancer; Oncology; Pharmacology; Biology; Signal transduction; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001075718,0.0003472342,0.0005536039,0.00008421365,0.0002913668,0.000137683,0.0008875258,0.0001744232,0.00002870066],"category_scores_gemma":[0.000268322,0.0001663513,0.0001956057,0.0004279409,0.0004910186,0.0000599053,0.0001330797,0.0006959314,7.072151e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001899394,"about_ca_system_score_gemma":0.0007715856,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002234331,"about_ca_topic_score_gemma":0.002649616,"domain_scores_codex":[0.996738,0.0005092241,0.0009191503,0.0003937842,0.000945422,0.0004944454],"domain_scores_gemma":[0.9973784,0.0001412604,0.001270002,0.0005143132,0.0006148374,0.00008119379],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3403562,0.0131071,0.08490962,0.0004809852,0.001766024,0.0002252128,0.004577234,0.02282916,0.4041455,0.000170958,0.02104972,0.1063823],"study_design_scores_gemma":[0.4603485,0.02786616,0.1500522,0.005409777,0.0006371274,0.0003579177,0.001176469,0.000460155,0.3141556,0.0002255559,0.03742625,0.001884268],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951281,0.001187988,0.0001422203,0.001040309,0.0009811718,0.001380588,0.00008296551,0.000006631507,0.00005004416],"genre_scores_gemma":[0.997481,0.0003535531,0.00007704076,0.000544276,0.001258018,0.0001165869,0.00002338647,0.00006919828,0.00007690158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1199923,"threshold_uncertainty_score":0.6783609,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006350034164310448,"score_gpt":0.2746686210074111,"score_spread":0.2683185868431006,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}